Correlation Between Medivie Therapeutic and Analyst IMS

Can any of the company-specific risk be diversified away by investing in both Medivie Therapeutic and Analyst IMS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medivie Therapeutic and Analyst IMS into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medivie Therapeutic and Analyst IMS Investment, you can compare the effects of market volatilities on Medivie Therapeutic and Analyst IMS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medivie Therapeutic with a short position of Analyst IMS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medivie Therapeutic and Analyst IMS.

Diversification Opportunities for Medivie Therapeutic and Analyst IMS

-0.76

Correlation Coefficient

Medivie Therapeutic  Analyst IMS

Pay attention - limited upside

The 3 months correlation between Medivie and Analyst is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Medivie Therapeutic and Analyst IMS Investment in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Analyst IMS Investment and Medivie Therapeutic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medivie Therapeutic are associated (or correlated) with Analyst IMS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Analyst IMS Investment has no effect on the direction of Medivie Therapeutic i.e., Medivie Therapeutic and Analyst IMS go up and down completely randomly.

Pair Corralation between Medivie Therapeutic and Analyst IMS

Assuming the 90 days trading horizon Medivie Therapeutic is expected to under-perform the Analyst IMS. In addition to that, Medivie Therapeutic is 3.56 times more volatile than Analyst IMS Investment. It trades about -0.02 of its total potential returns per unit of risk. Analyst IMS Investment is currently generating about 0.57 per unit of volatility. If you would invest  376,500  in Analyst IMS Investment on September 28, 2024 and sell it today you would earn a total of  203,400  from holding Analyst IMS Investment or generate 54.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	97.87%
Values	Daily Returns

Medivie Therapeutic  vs.  Analyst IMS Investment

Medivie Therapeutic

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medivie Therapeutic has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Analyst IMS Investment

Risk-Adjusted Performance

44 of 100

Excellent

Compared to the overall equity markets, risk-adjusted returns on investments in Analyst IMS Investment are ranked lower than 44 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Analyst IMS sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Medivie Therapeutic and Analyst IMS

The main advantage of trading using opposite Medivie Therapeutic and Analyst IMS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medivie Therapeutic position performs unexpectedly, Analyst IMS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Analyst IMS will offset losses from the drop in Analyst IMS's long position.

The idea behind Medivie Therapeutic and Analyst IMS Investment pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.